FDA DEVICE FACTS
ATTEST Drug Screen Cup, ATTEST Drug Screen Dip Card
Advin Biotech, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ATTEST Drug Screen Cup and the ATTEST Drug Screen Dip Card are rapid lateral flow immunoassays for the qualitative detection of 6-Acetylmorphine, d-Amphetamine, Benzoylecgonine, Buprenorphine, EDDP, d/l-Methadone, d- Methamphetamine, d/lMethylenedioxymethamphetamine, Morphine, Nortriptyline, Oxazepam, Oxycodone, Phencyclidine, d-Propoxyphene, Secobarbital and THC-COOH in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Analyte Calibrator Cutoff (ng/mL) 6-Acetylmorphine 6-monoacetylmorphine 10 Amphetamine d-Amphetamine 500 Amphetamine d-Amphetamine 1,000 Barbiturates Secobarbital/Pentobarbital 300 Benzodiazepines Oxazepam 300 Buprenorphine Buprenorphine 10 EDDP 2-ethylidene-1,5-dimethyl-3-3- diphenylpyrrolidine 300 Cocaine Benzoylecgonine 150 Cocaine Benzoylecgonine 300 Ecstasy d,l-Methylenedioxymethamphetamine 500 Methamphetamine d-Methamphetamine 500 Methamphetamine d-Methamphetamine 1,000 Marijuana 11-nor-Δ 9-THC-9-COOH 50 Methadone d/l-Methadone 300 Opiates Morphine 300 Opiates Morphine 2,000 Oxycodone Oxycodone 100 Phencyclidine Phencyclidine 25 Propoxyphene Propoxyphene 300 Tricyclic Antidepressants Nortriptyline 1,000 The single or multi-test panels can consist of the above listed analytes in any combination, up to a maximum of 16 analytes, with and without on-board adulteration/specimen validity tests (SVT) in the dip card format and in the cup format. The drug screen tests are intended for prescription use only. The tests provide only a preliminary result. A more specific alternative chemical method should be used in order to obtain a confirmed presumptive positive result if the donor doesn’t admit use or anytime required by testing procedures. Gas Chromatography / Mass Spectrometry (GC/MS), Liquid Chromatography / Mass Spectrometry (LC/MS) and their tandem mass-spectrometer versions are the preferred confirmatory methods. Careful consideration and judgment should be applied to any drugs of abuse screen test result, particularly when evaluating preliminary positive results.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。